Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190804044429N12
IRCT20190804044429N12
Recruiting
Phase 3

The effects of synbiotic product on gut microbiota changes in patients with multiple sclerosis treated with dimethyl fumarate: A randomized, double-blind, placebo-control clinical trial

Mazandaran University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMultiple sclerosis.Multiple sclerosis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Multiple sclerosis.
Sponsor
Mazandaran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Adults over 18 years of age with a recent diagnosis of MS or a first attack consistent with a high\-risk primary clinical syndrome based on the McDonald 2017 criteria
  • •Expanded disability status scale less than 4\.5
  • •Candidate for dimethyl fumarate

Exclusion Criteria

  • •Antibiotic use in the past month
  • •Consumption of any product and supplement that contains probiotics during the last three months
  • •Consumption of omega\-3 and other antioxidants during the last month
  • •Systemic glucocorticoid use during the last month
  • •breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Effects of diets containing synbiotics on gut microbiota of critically ill septic patientsSepsis is a life&#45threatening condition&#44and is a common cause of death despite advances in the supportive care of the critically ill.Sepsis&#44probiotics&#44gut microbiota
TCTR20191017004Faculty of Medicine, Prince of Songkla University24
Recruiting
Not Applicable
Evaluation of the use of Probiotics in the intestinal flora, nutritional status and immune system of patients who underwent Surgery to Remove the Stomach for Gastric CancerGastric NeoplasmsGastrectomyG06.591.375
RBR-5vyr8bpFAM- Universidade Federal do Amazonas
Recruiting
Not Applicable
The effect of probiotics on intestinal microbiota
IRCT20220406054437N2Shahid Beheshti University of Medical Sciences50
Recruiting
Phase 3
Synbiotic and gut microbiome
IRCT20180624040228N2Yazd Diabetes Research Center72
Completed
Phase 2
The effect of Synbiotics and Probiotics supplementation in reducing cardiovascular complications in hemodialysis patientshemoldialysis.Extracorporeal dialysis
IRCT2017041233393N1Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences75